Biomechanical modelling of the pelvic system: improving the accuracy of the location of neoplasms in MRI-TRUS fusion prostate biopsy

dc.contributor.authorQasim, Muhammad
dc.contributor.authorPuigjaner, Dolors
dc.contributor.authorHerrero, Joan
dc.contributor.authorLópez, Josep M.
dc.contributor.authorOlivé, Carme
dc.contributor.authorFortuny, Gerard
dc.contributor.authorGarcia Bennett, Josep
dc.date.accessioned2022-04-19T13:01:58Z
dc.date.available2022-04-19T13:01:58Z
dc.date.issued2022-03-28
dc.date.updated2022-04-19T09:07:36Z
dc.description.abstractBackground An accurate knowledge of the relocation of prostate neoplasms during biopsy is of great importance to reduce the number of false negative results. Prostate neoplasms are visible in magnetic resonance images (MRI) but it is difficult for the practitioner to locate them at the time of performing a transrectal ultrasound (TRUS) guided biopsy. In this study, we present a new methodology, based on simulation, that predicts both prostate deformation and lesion migration during the biopsy. Methods A three-dimensional (3-D) anatomy model of the pelvic region, based on medical images, is constructed. A finite element (FE) numerical simulation of the organs motion and deformation as a result of the pressure exerted by the TRUS probe is carried out using the Code-Aster open-source computer software. Initial positions of potential prostate lesions prior to biopsy are taken into consideration and the final location of each lesion is targeted in the FE simulation output. Results Our 3-D FE simulations show that the effect of the pressure exerted by the TRUS probe is twofold as the prostate experiences both a motion and a deformation of its original shape. We targeted the relocation of five small prostate lesions when the TRUS probe exerts a force of 30 N on the rectum inner wall. The distance travelled by these lesions ranged between 5.6 and 13.9 mm. Conclusions Our new methodology can help to predict the location of neoplasms during a prostate biopsy but further studies are needed to validate our results. Moreover, the new methodology is completely developed on open-source software, which means that its implementation would be affordable to all healthcare providers.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1471-2407
dc.identifier.pmid35351051
dc.identifier.urihttps://hdl.handle.net/2445/184999
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12885-022-09432-4
dc.relation.ispartofBMC Cancer, 2022, vol. 22, num. 1
dc.relation.urihttps://doi.org/10.1186/s12885-022-09432-4
dc.rightscc by (c) Qasim, Muhammad et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer de pròstata
dc.subject.classificationDiagnòstic
dc.subject.otherProstate cancer
dc.subject.otherDiagnosis
dc.titleBiomechanical modelling of the pelvic system: improving the accuracy of the location of neoplasms in MRI-TRUS fusion prostate biopsy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s12885-022-09432-4.pdf
Mida:
1.97 MB
Format:
Adobe Portable Document Format